Michael Bowers

Michael Bowers began their work experience as a Chemist at Fibrant in May 2012 and held this position until March 2017. Michael then joined The Ritedose Corporation (TRC) in March 2017 as a QC Analytical Chemist II and worked there until March 2018. After that, they joined AmbioPharm - A Global Peptide CDMO in March 2018 as a QC Analytical Chemist Lead and held this role until February 2020. Subsequently, they became a Quality Control Stability Supervisor at AmbioPharm from February 2020 to April 2022. Currently, they serve as a Quality Control Scientific Manager at AmbioPharm, starting from February 2022.

Michael Bowers attended Georgia Southern University from 2004 to 2009, where they obtained a Bachelor of Science (B.S.) degree in Chemistry.